Skip to main content

Table 1 Cleavage and blastocyst formation across each study

From: Interleukin-6 increases inner cell mass numbers in bovine embryos

Study

Treatment

Treatment dates(s)

IVF replicates

Total embryos

Cleavage*

Day 7 blastocyst*

Day 8 blastocyst*

A

0 ng/ml IL6

Day 5

4

317

N/A

12.8 ± 1.3a

21.8 ± 3a

1 ng/ml IL6

Day 5

316

10.8 ± 1.4a

21.8 ± 3.7a

10 ng/ml IL6

Day 5

323

16.8 ± 3.3a

23.7 ± 4.6a

100 ng/ml IL6

Day 5

320

12.7 ± 4.2a

23.7 ± 6.3a

B

0 ng/ml IL6

Day 3

6

240

N/A

10.8 ± 4a

24.2 ± 6.3a

100 ng/ml IL6

Day 3

240

14.6 ± 3.4a

30.4 ± 6.8a

100 ng/ml IL6

Day 5

240

13.8 ± 3.3a

25.8 ± 6.9a

100 + 100 ng/ml IL6

Day 3 + 5

240

12.5 ± 4.8a

32.9 ± 6.4a†

C

0 ng/ml IL6

Day 1

4

249

73.4 ± 3.7a

12.3 ± 4.2a

20.1 ± 3.5a

1 ng/ml IL6

Day 1

297

80.1 ± 5.9a†

17.9 ± 2.5a

27.1 ± 2.4a

10 ng/ml IL6

Day 1

301

76.4 ± 5.6a

18.1 ± 3.7a

27.7 ± 4.7a

100 ng/ml IL6

Day 1

248

76.4 ± 3.6a

19.4 ± 4.1a

29.6 ± 4.2a

D

0 ng/ml IL6

Day 1

6

395

74.8 ± 4.5a

11.5 ± 1 a

20.3 ± 2.1 a

100 ng/ml IL6

Day 1

437

76.8 ± 2.2a

10.8 ± 1.7 a

21.5 ± 2.5 a

100 ng/ml IL6

Day 5

392

77.8 ± 3.8a

10.9 ± 1 a

21.6 ± 2.4 a

100 + 100 ng/ml IL6

Day 1 + 5

440

75.2 ± 5.2a

10.2 ± 1.8 a

19.4 ± 3.7 a

200 ng/ml IL6

Day 1

418

76.7 ± 3.7a

9.8 ± 1.6 a

18.9 ± 1.7 a

E

0 ng/ml IL6

Day 5

4

347

87.7 ± 0.1a

15.8 ± 0.1a

27.9 ± 0.1a

100 ng/ml IL6

Day 5

337

85.3 ± 0.1a

17.4 ± 0.1a

26.1 ± 0.1a

200 ng/ml IL6

Day 5

392

83.9 ± 0.1a

20.5 ± 0.1a

30.4 ± 0.1a

100 + 100 ng/ml IL6

Day 1 + 5

357

81.1 ± 0.1a

18.9 ± 0.1a

29.1 ± 0.1a

F

0 ng/ml IL6 (Group)

Day 1

4

175

138/175a

17/138a

29/138a

Individual

      

0 ng/ml

Day 1

 

100

65/100b

0/65b

0/65b

100 + 100 ng/ml IL6

Day 1 + 4

100

79/100a

0/79b

7/79c

200 ng/ml IL6

Day 1

100

73/100ab

0/73b

7/73c

  1. Different superscripts within each study denote differences. Significance established at P < 0.05
  2. † indicates a trend (P = 0.06 in study B and P = 0.09 in Study C) when compared with the control)
  3. *Data for studies A-E are presented as the Mean% ± SEM. Data from study F are presented as proportions